T cell immunoglobulin and mucin domain 3 (TIM3) expression is associated with immunosuppression and clinical outcomes in many diseases. However, the specific mechanism of TIM3 in immune system has not been clarified. In order to illustrate the mechanism of TIM3 in immune system, we analyzed the expression, function and regulation of TIM3 in T helper (Th)1 cells, Th2 cells, Th17 cells and regulatory T cells (Treg) through flow cytometry in patients with myelodysplastic syndrom (MDS). Our data showed elevated proportion of Th2 and Treg cells, while the proportion of Th1 and Th17 cells decreased in patients with MDS (p<0.05) and the expression of TIM3 increased in Th1, Th17 and Treg cells in patients with MDS when compared with expression in control patients (p<0.05). The secretion of transforming growth factor-β in TIM3+Treg cells decreased in patients with MDS. These findings suggested that TIM3 might affect immune helper systems by regulating Treg cells and related immune cells. Therefore, studying the role of the TIM3 pathway in MDS is necessary and may help to provide a new way to explore the pathogenesis and treatments of MDS.
LiLJ, TaoJL, FuR, Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML. Int J Hematol2014;100:60–9.doi:10.1007/s12185-014-1590-2
3.
JiangH, FuR, WangH, . CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome. Leuk Res2013;37:907–10.doi:10.1016/j.leukres.2013.04.008
4.
TaoJ, LiL, WangY, . Increased TIM3+CD8+T cells in Myelodysplastic Syndrome patients displayed less perforin and granzyme B secretion and higher CD95 expression. Leuk Res2016;51:49–55.doi:10.1016/j.leukres.2016.11.003
5.
SeversonJJ, SerracinoHS, MateescuV, . PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res2015;3:620–30.doi:10.1158/2326-6066.CIR-14-0201
6.
SakuishiK, JayaramanP, BeharSM, . Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol2011;32:345–9.doi:10.1016/j.it.2011.05.003
7.
ZhuC, AndersonAC, KuchrooVK. TIM-3 and its regulatory role in immune responses[M] Negative Co-Receptors and Ligands. Springer Berlin Heidelberg2010;32:1–15.
8.
ZhangY, MaCJ, WangJM, . Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes. J Leukoc Biol2012;91:189–96.doi:10.1189/jlb.1010591
9.
LeeSY, GovermanJM. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells. J Immunol2013;190:4991–9.doi:10.4049/jimmunol.1300083
10.
JostS, Moreno-NievesUY, Garcia-BeltranWF, . Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection. Retrovirology2013;10:1): 1.doi:10.1186/1742-4690-10-74
11.
AditiS, BrittaW, UlrichS, . Stem and progenitor cell alterations in myelodysplastic syndromes. Blood2017.
12.
GreenbergPL, TuechlerH, SchanzJ, . Revised international prognostic scoring system for myelodysplastic syndromes. Blood2012;120:2454–65.doi:10.1182/blood-2012-03-420489
13.
BigbyM, WangP, FierroJF, . Phorbol myristate acetate-induced down-modulation of CD4 is dependent on calmodulin and intracellular calcium. J Immunol1990;144:3111–6.
14.
JiangHJ, FuR, WangHQ, . Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome. Chin Med J2013;126:2582–4.
15.
ParkH, LiZ, YangXO, . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol2005;6:1133–41.doi:10.1038/ni1261
16.
LiJ, YueL, WangH, . Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells. J Immunol Res2016;2016:1–14.doi:10.1155/2016/9404705
17.
ZhuC, AndersonAC, SchubartA, . The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol2005;6:1245–52.doi:10.1038/ni1271
18.
SekiM, OomizuS, SakataK-mei, . Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clinical Immunology2008;127:78–88.doi:10.1016/j.clim.2008.01.006
19.
Rodriguez-ManzanetR, DeKruyffR, KuchrooVK, . The costimulatory role of TIM molecules. Immunol Rev2009;229:259–70.doi:10.1111/j.1600-065X.2009.00772.x
20.
SekiM, OomizuS, SakataKM, . Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol2008;127:78–88.doi:10.1016/j.clim.2008.01.006
21.
McMahanRH, Golden-MasonL, NishimuraMI, . Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest2010;120:4546–57.doi:10.1172/JCI43127
22.
LiS, PengD, HeY, . Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis. APMIS2014;122:899–904.doi:10.1111/apm.12228
23.
PieterseE, van der VlagJ. Breaking immunological tolerance in systemic lupus erythematosus[J]. Front Immunol2014;56:624–9.
24.
KanaiY, SatohT, IgawaK, . Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis. Acta Derm Venereol2012;92:367–71.doi:10.2340/00015555-1285
25.
AraújoMI, HoppeBS, MedeirosM, . Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem Inst Oswaldo Cruz2004;99:27–32.doi:10.1590/S0074-02762004000900005
